Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection.

Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D, Szabo G.

J Transl Med. 2012 Jul 30;10:151. doi: 10.1186/1479-5876-10-151.

2.

Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.

Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G.

Gastroenterology. 2007 Nov;133(5):1627-36. Epub 2007 Aug 2.

3.

Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C.

Zhang WJ, Wang H, Tong QX, Jie SH, Yang DL, Peng C.

J Huazhong Univ Sci Technolog Med Sci. 2015 Apr;35(2):219-24. doi: 10.1007/s11596-015-1414-5. Epub 2015 Apr 16.

PMID:
25877355
4.

Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.

Motawi TM, Sadik NA, Shaker OG, Ghaleb MH.

Tumour Biol. 2016 Jul;37(7):9865-74. doi: 10.1007/s13277-016-4884-6. Epub 2016 Jan 26.

PMID:
26812693
5.

Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.

Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W.

Int J Med Sci. 2015 Jul 16;12(7):590-8. doi: 10.7150/ijms.11525. eCollection 2015.

6.

Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.

El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.

Mol Diagn Ther. 2015 Aug;19(4):213-20. doi: 10.1007/s40291-015-0148-1.

PMID:
26133725
7.

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.

Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A.

Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24.

PMID:
21606975
8.

Differences in serum microRNA profiles in hepatitis B and C virus infection.

Akamatsu S, Hayes CN, Tsuge M, Miki D, Akiyama R, Abe H, Ochi H, Hiraga N, Imamura M, Takahashi S, Aikata H, Kawaoka T, Kawakami Y, Ohishi W, Chayama K.

J Infect. 2015 Mar;70(3):273-87. doi: 10.1016/j.jinf.2014.10.017. Epub 2014 Nov 5.

PMID:
25452043
9.

Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.

Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J, Alao H, Kodys K, Szabo G.

Hepatology. 2012 Nov;56(5):1946-57. doi: 10.1002/hep.25873. Epub 2012 Jul 26.

10.

Inhibitory effect of miR-125b on hepatitis C virus core protein-induced TLR2/MyD88 signaling in THP-1 cells.

Peng C, Wang H, Zhang WJ, Jie SH, Tong QX, Lu MJ, Yang DL.

World J Gastroenterol. 2016 May 7;22(17):4354-61. doi: 10.3748/wjg.v22.i17.4354.

11.

Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections.

Liu BS, Groothuismink ZM, Janssen HL, Boonstra A.

J Leukoc Biol. 2011 Jun;89(6):981-8. doi: 10.1189/jlb.1210680. Epub 2011 Mar 8.

PMID:
21385948
12.

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.

van der Meer AJ, Farid WR, Sonneveld MJ, de Ruiter PE, Boonstra A, van Vuuren AJ, Verheij J, Hansen BE, de Knegt RJ, van der Laan LJ, Janssen HL.

J Viral Hepat. 2013 Mar;20(3):158-66. doi: 10.1111/jvh.12001. Epub 2012 Aug 27.

PMID:
23383654
13.

Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy.

Köberle V, Waidmann O, Kronenberger B, Andrei A, Susser S, Füller C, Perner D, Zeuzem S, Sarrazin C, Piiper A.

J Viral Hepat. 2013 Aug;20(8):530-5. doi: 10.1111/jvh.12075. Epub 2013 Feb 18.

PMID:
23808991
14.

Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.

Liu B, Xiang Y, Zhang HS.

Mol Med Rep. 2015 Jul;12(1):105-10. doi: 10.3892/mmr.2015.3386. Epub 2015 Feb 24.

15.

The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.

Ninomiya M, Kondo Y, Kimura O, Funayama R, Nagashima T, Kogure T, Morosawa T, Tanaka Y, Nakayama K, Shimosegawa T.

J Viral Hepat. 2016 May;23(5):330-9. doi: 10.1111/jvh.12522. Epub 2016 Feb 29.

PMID:
26924666
16.

Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.

Dubin PH, Yuan H, Devine RK, Hynan LS, Jain MK, Lee WM; Acute Liver Failure Study Group..

J Med Virol. 2014 Sep;86(9):1507-14. doi: 10.1002/jmv.23987. Epub 2014 Jun 4.

17.

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.

Lee TH, Matta B, King BD, Hodges MR, Tillmann HL, Patel K.

J Med Virol. 2015 Oct;87(10):1722-6. doi: 10.1002/jmv.24230. Epub 2015 May 11.

PMID:
25963774
18.

Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.

Oliveira KG, Malta FM, Nastri AC, Widman A, Faria PL, Santana RA, Alves VA, Carrilho FJ, Pinho JR.

Med Microbiol Immunol. 2016 Apr;205(2):111-7. doi: 10.1007/s00430-015-0431-0. Epub 2015 Aug 14.

PMID:
26272127
19.

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L.

PLoS One. 2011;6(8):e23937. doi: 10.1371/journal.pone.0023937. Epub 2011 Aug 23.

20.

Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.

Hsi E, Huang CF, Dai CY, Juo SH, Chou WW, Huang JF, Yeh ML, Lin ZY, Chen SC, Wang LY, Chuang WL, Yu ML.

Antiviral Res. 2014 May;105:135-42. doi: 10.1016/j.antiviral.2014.03.003. Epub 2014 Mar 15.

PMID:
24637254

Supplemental Content

Support Center